-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management_research-protocol.pdf
January 01, 2014 - services include providing education and counseling, improving medication adherence, and
detecting adverse … drug events and medication misuse.2 MTM services are designed to be distinct
from medication-dispensing … Populations
Medication misuse and poor medication adherence commonly contribute to adverse events … drug events, missed days of work/school, patient satisfaction with care, health-related
quality of … events,
and better or more efficient coordination of care.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd_research-protocol.pdf
August 10, 2010 - children < 6 years of age with ADHD or Disruptive Behavior
Disorder, what are the effectiveness and adverse … Among people 6 years of age or older with ADHD, what are the
effectiveness and adverse event outcomes … • Descriptive Statistics
Outcomes Numerical or statistical
results of any
effectiveness or adverse … event outcomes
Numerical or statistical
results of any
effectiveness or adverse
event outcomes … events:
physical
changes:
stomachaches,
tics, weight loss,
slowed growth,
cardiac events
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-e1.xlsx
March 13, 2023 - Adverse Events
Table E-4. … Cannabis RCTs adverse events
Author, Year Companion Paper Risk of Bias Pain Population Category Specific … In addition,
the number of reported adverse events in the nabilone/
GBP group decreased by 27% from Visits … events in the study. … Cannabis RCTs adverse events
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-tables-F1-4.xlsx
January 01, 2022 - Adverse Events
Table F-4. … Cannabis RCTs adverse events
Author, Year Companion Paper Risk of Bias Pain Population Category Specific … In addition,
the number of reported adverse events in the nabilone/
GBP group decreased by 27% from Visits … events in the study. … Cannabis RCTs adverse events
-
effectivehealthcare.ahrq.gov/products/acs-pci-adjunctive-devices/research-protocol
July 01, 2010 - larger infarcts, more significant left ventricular systolic dysfunction, and an increased risk of major adverse … cardiovascular events (MACE) or death. … events (e.g., coronary dissection, perforation, prolonged procedure time) differ between device types … events, had an adequate sample size, and used intention-to-treat analysis. 11 Studies meeting fewer … between patients in the study and the community
Eligibility criteria, demographics
Population
Events
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
January 01, 2011 - Effect Methods Group57
and other experts.58,59
Adverse Effects/Harms
A search for adverse effects … DISEASES/ci
Drug terms AND Exp LIVER
DISEASE/si
subheadings linked to drug name Exp DRUG NAMEadverse events … ,
po, to
Exp DRUG NAMEadverse events, to
floating subheadings Drug terms AND (ae OR po OR to
OR … (effect or effects
or reaction or reactions or event or
events or outcome or outcomse)])
Drug terms … adj2 (effect or effects
or reaction or reactions or event or
events or outcome or outcomse)])
indexing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
February 01, 2008 - brachytherapy (103Pd) implant
found no significant differences in the number of
biochemical failure events … Adverse effects were reported, but definitions and
severity varied widely. … • Distant metastases: No significant difference in distant failure
events between groups at the median … Biochemical/clinical progression or recurrence: No difference in
6.5 weeks) compared with PSA relapse events … significant
of different regimens differences between 20 Gy and 44 Gy in the number of
biochemical failure events
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-F1-4.xlsx
January 01, 2022 - Adverse Events
Table F-4. … Cannabis RCTs adverse events
Author, Year Companion Paper Risk of Bias Pain Population Category Specific … In addition,
the number of reported adverse events in the nabilone/
GBP group decreased by 27% from Visits … events in the study. … Cannabis RCTs adverse events
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-E-1-E-4.xlsx
January 01, 2023 - Adverse Events
Table E-4. … Cannabis RCTs adverse events
Author, Year Companion Paper Risk of Bias Pain Population Category Specific … In addition,
the number of reported adverse events in the nabilone/
GBP group decreased by 27% from Visits … events in the study. … Cannabis RCTs adverse events
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-F.xlsx
January 01, 2023 - Adverse Events
Table F-4. … Cannabis RCTs adverse events
Author, Year Companion Paper Risk of Bias Pain Population Category Specific … In addition,
the number of reported adverse events in the nabilone/
GBP group decreased by 27% from Visits … events in the study. … Cannabis RCTs adverse events
-
effectivehealthcare.ahrq.gov/products/diabetes-claims-data/research
April 07, 2010 - For the clinical goal of assessing medication use in DMT2 patients, we focused on patients with adverse … DMT2 NC Medicaid patients, we identified 49 who had an MI, 173 who had a stroke, and 14 who had both events … extraction of clinically relevant text data regarding historical notations, negation, diagnostic issues, and adverse … With regard to the clinical goal of this project, patients who suffered adverse outcomes (MI, stroke, … These patients had relatively high utilization of care in the year before the adverse outcome, suggesting
-
effectivehealthcare.ahrq.gov/products/erythropoiesis-stimulating-agents-utilization/research
March 31, 2011 - to 12 grams per dL.5 A number of published studies, beginning in the late 1990s, suggested potential adverse … beneficiaries with kidney disease (KD) and to relate these trends to the timing of clinical practice and policy events
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf
November 01, 2014 - adverse
drug events, many patients do not receive
optimal pharmaceutical prescriptions. … drug events. … drug events
or mortality (Table D). … drug events, prescriber confusion, and prescriber
dissatisfaction. … events.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
April 01, 2013 - to adverse effects. … , intervention-group rates of events, or both. … • Health-related quality of life and serious adverse events
were inconsistently reported in the seven … For adverse effects, we considered
discontinuation due to adverse effects and worsening of
psychiatric … , and
adverse events
Improved reporting of efficacy–effectiveness
characteristics
CATIE = Clinical
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
September 13, 2013 - stratify the findings of the previous
review, as well as any newly included studies on efficacy and adverse … or symptoms
Cerebrovascular events
Peripheral vascular events or symptoms
Cardiovascular death … strength
Source: www.effectivehealthcare.ahrq.gov
Published online: June 10, 2013
4
o Adverse … mortality
Cancer and cancer-specific mortality
Renal outcomes
Soft tissue calcification
(Other) adverse … For upper limit
(adverse event [AE]) outcomes, we will include any adverse effects of high intake in
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/aggression_executive.pdf
October 01, 2016 - One RCT43 examined three possible harms: drug-related
adverse effects; incidence of abnormal QT (QRS … flunitrazepam, no statistical testing
reported (3 vs. 3, p=NR).48
Drug-related
adverse events
91 … Few overall treatment-emergent
adverse events with olanzapine
vs. risperidone vs. haloperidol,
p … =NR.72
Adverse events
considered
related to
primary
antipsychotic
medication
558
Insufficient … No significant difference in
discontinuation due to clinically
significant adverse events with
olanzapine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - Mitigation of long-term adverse effects by changes in regimen, including reduced-intensity
approaches … But, it is well recognized that regimens vary in their
potential for long-term adverse effects. … Patients
will need to be
followed for at least
5 years for enough
events to occur to
enable a
comparison … Patients will
need to be followed for
at least 5 years for
enough events to occur
to enable a comparison … Events
This study
is ongoing,
but not
recruiting
participants.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - • No adverse events, except for a few cases of nausea,
were reported in the trial evaluating bupropion … Risk of withdrawal due to adverse events
appeared to differ between dopamine agonists (I2=73%,
p=0.02 … events were reported. … events, and augmentation). … About half of withdrawals were due to adverse events,
including augmentation; 20 percent to 30 percent
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_research-protocol.pdf
October 18, 2010 - events
associated with this therapy.†
* Also see: Witter … While we
agree there might be benefits to investigating serious and rare adverse events in an
hypothesis … events
Maternal side effects (pulmonary edema, heart failure, arrhythmia,
myocardial infarction, … Further, data will be extracted as number of patients with an event (as opposed to
number of events) … For rare outcomes,
only studies with events recorded will be included in combined estimates.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_executive.pdf
May 01, 2013 - is the comparative effectiveness of aspirin
and other antiplatelet agents in reducing the
risk of adverse … What are the significant safety concerns associated
with each treatment strategy (e.g., adverse drug … What are the significant safety concerns associated
with each treatment strategy (e.g., adverse drug … What are the significant safety concerns associated
with each treatment strategy (e.g., adverse
drug … Some RCTs
reported adverse events such as rash and wound leak.